Electrocardiogram (ECG) Devices Market, By Product (Rest ECG Systems, Stress ECG Systems, Holter ECG Systems, Event Recorders, and Other Products), By Technology (Portable ECG Systems and Wireless ECG Systems), By Lead Type (Single Lead ECG, 3-6 Lead ECG, and 12 Lead ECG), By End User (Home-based Users, Hospitals, and Other End Users), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jun 2023

Code : CMI2657

Pages :145

Formats :

Excel and PDF

Industry : Medical Devices

Electrocardiogram (ECG) Devices MarketSize and Trends

The global electrocardiograph market was valued at US$ 5,719.7 Mn in 2022 and is forecast to reach a value of US$ 8,004.2 Mn by 2030 at a CAGR of 4.3%between 2023 and 2030. The global electrocardiograph market is experiencing strong growth due to the rise in burden of cardiovascular disease (CVDs) and growing geriatric population across the globe. Moreover, increasing demand for ECG for the diagnosis of cardiac disorders and increasing adoption/demand for technologically advanced ECG monitors is expected to propel the growth of the market.

Global Electrocardiograph Market

Global Electrocardiograph Market Trends:

Rise in demand for portable ECG monitors is a recent trend

Holter ECG system is a type of portable electrocardiogram (ECG). It records the electrical activity of the heart continuously over 24 hours or longer. It is used to detect and/or determine the risk of irregular heartbeats (arrhythmias). Moreover, the Holter ECG provide a complete picture of heart activity necessary for the diagnosis of cardiac conditions. Therefore, there is an increasing demand for technologically advanced portable and compact ECG monitors across the globe. This trend is expected to continue over the forecast period.

Introduction of novel products is another trend

Players in the market are focusing on developing and launching novel products, ECG monitors, to meet the increasing demand for technologically advanced or portable and compact ECG monitors. In September 2020, AliveCor announced the launch of, KardiaMobile 6L, its clinically-validated personal ECG device. It can detect three most common arrhythmias or irregular heartbeat, such as atrial fibrillation (AFib), bradycardia, and tachycardia. The device is small enough to fit in a pocket and gives patients the ability to record a medical-grade ECG in just 30 seconds.